- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Diabetes Costs Patients an Additional $10,000 Annually
The average per capita spending difference between people with and without diabetes was $10,310 from 2009 to 2013, according to a new report from the Health Care Cost Institute.
Diabetes is a costly chronic condition in the United States, medical costs and productivity loss attributable to diabetes were estimated to be $245 billion in 2012.
An issue brief from the Health Care Cost Institute, compared per capita spending for people with a diagnosis of diabetes for individuals covered by employer-sponsored insurance and younger than age 65 with those without a diagnosis for the years 2009 through 2013. During that period, spending for individuals with diabetes increased by roughly $1000 to about $15,000 per capita.
The average per capita spending difference between people with and without diabetes was $10,310. Additionally, during this period, people with diabetes spent on average 2.5 times more out of pocket than people without diabetes. Among individuals with diabetes, children (ages 0 through 18) and pre-Medicare adults (ages 55 through 64) were the 2 groups with the highest per capita healthcare spending in every year of the study period.
Read more at the Health Care Cost Institute: http://bit.ly/1H5n857
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
